Helix BioMedix, Inc. (HXBM)
OTCMKTS · Delayed Price · Currency is USD
1.020
0.00 (0.00%)
At close: Jul 27, 2026
Helix BioMedix Market Cap
Helix BioMedix has a market cap or net worth of $229.2 thousand as of July 30, 2026. Its market cap has decreased by -82.01% in one year.
Market Cap
229.20K
Enterprise Value
n/a
Revenue
2.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.02
ChartMarket Cap Chart
Since July 26, 1995, Helix BioMedix's market cap has decreased from 1.59M to 229.20K, a decrease of -85.63%. That is a compound annual growth rate of -6.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 229.20K | -49.00% |
| Dec 31, 2025 | 449.42K | -75.00% |
| Dec 26, 2024 | 1.80M | -76.87% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| inTerra Resources | 443.23K |
| Actavia Life Sciences | 385.91K |
| Innovation Pharmaceuticals | 317.26K |
| Altamira Therapeutics | 284.06K |
| Sorrento Therapeutics | 271.86K |
| Protagenic Therapeutics | 232.07K |
| Ampio Pharmaceuticals | 207.88K |
| CNBX Pharmaceuticals | 160.58K |